In March 2009, the Pharma Index was trading at 2020. For the next 6 years until March 2015, Pharma had a continued rally to make a high of 14,020. Thereafter in March 2016, the Pharma Index witnessed highest correction in 7 years to make a low of 10,353. Currently it stands at 11,100.
The Pharma Sector has been all-time performer. However, the recent USFDA inspections have caused a few hiccups leading to correction. As most Pharma companies export in bulk and Rupee is currently at its all-time low (Dollar appreciation against Rupee), the Pharma sector has witnessed buying and profitability.
Rise in share price of Major Pharma Companies Post Budget (since Feb 2016):
| Stocks | Current Share Price (in Rs.) | Rise in Share Price (%) |
598.55
|
237.12
| |
502
|
141.06
| |
711.9
|
133.26
| |
149.1
|
109.26
| |
596.3
|
108.31
| |
100
|
104.29
| |
925.05
|
97.03
| |
368
|
95.91
| |
1009
|
92.72
| |
715.5
|
85.8
| |
1673.7
|
84.31
| |
225
|
80.14
| |
664.9
|
67.29
| |
239.15
|
60.67
| |
998
|
52.77
| |
559.4
|
47.91
| |
580.3
|
46.73
| |
607.3
|
46
| |
350.25
|
44.64
| |
21.75
|
43.09
| |
1862
|
43.01
| |
1180
|
42.74
| |
637.5
|
38.03
| |
1715
|
35.61
| |
266.9
|
34.73
| |
197
|
34.52
| |
48
|
27.83
| |
124.25
|
27.83
| |
44
|
26.26
| |
396.4
|
26
| |
97
|
25.08
| |
1098
|
24.84
| |
1169.75
|
23.06
| |
316
|
22.41
| |
216.35
|
20.13
| |
878.3
|
19.39
| |
50
|
18.91
| |
102.3
|
18.27
| |
180.75
|
18.1
| |
7.35
|
17.6
| |
98
|
17.08
| |
38.5
|
16.31
| |
741.65
|
13.12
| |
1420.45
|
12.64
| |
4.3
|
11.69
| |
6
|
11.11
| |
570
|
10.86
| |
6.7
|
10.74
| |
29.3
|
7.13
| |
179
|
6.96
| |
22.4
|
6.67
| |
38.1
|
6.57
| |
157.4
|
6.21
| |
3206
|
5.59
| |
34.8
|
5.14
| |
649.15
|
5.03
| |
35.65
|
3.94
| |
901.2
|
3.34
| |
109.15
|
2.73
| |
4391.2
|
1.7
| |
39.55
|
1.41
| |
572.35
|
1.35
| |
4846.05
|
1.25
| |
4.65
|
1.09
|
The Indian pharmaceutical sector has the potential to grow and increase to the size of 300 billion dollars by the year 2030 from the current 15 billion dollars provided it accords high priority on quality and R&D – research & development, chief executives of top pharmaceutical companies stated.
They said that the Indian firms must foster innovation and develop products for the benefit of the patients adding that companies must address quality compliance challenges and inculcate quality culture in the organisations to develop high quality medicines for all the markets.
Conclusion:
The Pharma Sector is showing a turnaround and many Pharma stocks are hitting 52 week highs. It was only today that Syngene share price touched 52 week high. This is creating an opportunity for other Pharma stocks to do well since the entire sector is performing well. It is an excellent time for Pharma stock lovers to invest. Dynamic Levels Research Analysts have recommended the following multibagger Pharma stocks which can be great for investment:
- Jubilant
- Syngene
- Hikal
- Neuland Lab
- RPG Life
- Piramal Enterprises
- Lincoln Pharma
Good Information. I have a question regard the stocks. Which is
ReplyDeleteI keep hearing it’s crucial to be diversified. Why?
glen india
what is stock market
marksans pharma news
colgate palmolive share price bse
top gainers today
v guard
stock recommendations for short term
type of share market